Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA.

ABSTRACT: Mycoplasma pneumoniae infections decreased in Ohio, USA, during the COVID-19 pandemic but reemerged in 2023; >2,000 cases were reported during September 2023--September 2024. Of 995 M. pneumoniae-positive samples, 24 (2.4%) had mutations for macrolide-resistant M. pneumoniae (MRMp). MRMp rates are low but increasing. MRMp surveillance is crucial for monitoring antimicrobial resistance.

SUBMITTER: Leber AL 

PROVIDER: S-EPMC11878328 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature